Learn more about whether BioCryst Pharmaceuticals, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether BioCryst Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

BioCryst Pharma's ORLADEYO leads HAE market growth, with strong financial performance and potential despite rising ...

Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it failed to reach the primary endpoint in a Phase II trial. Preliminary ...

Studies of treatment with neuraminidase inhibitors have not shown sufficient evidence that they prevent transmission to contacts. We conducted a multicountry, phase 3b trial to assess the efficacy ...

Computational Biophysics and CADD Group, Computational and Mathematical Biology Centre (CMBC), Translational Health Science and Technology Institute (THSTI), Faridabad 121001, India Delhi ...

inhibitor use in cats, specific to Senvelgo (velagliflozin oral solution) and Bexacat (bexagliflozin tablets). She discusses gastrointestinal symptoms, ketosis and diabetic ketoacidosis (DKA), ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

BALTIMORE, April 16, 2025--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

Concerns have arisen over JAK inhibitors' cardiovascular safety relative to TNF inhibitors and other biologic agents for rheumatoid arthritis. Registry data from more than 50,000 European patients ...

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), describes a sodium-glucose cotransporter-2 inhibitor in a dvm360 interview. In this interview with dvm360, Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), past ...

Koch Institute for Integrative Cancer Research, and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States The Broad Institute of ...